| Generic/Working Name | Alisertib |
| Trade Name | MLN8237 |
| Company Name | Millennium/Takeda |
| Drug Type | Small molecule |
| Drug Class | Mitotic ‐ Aurora kinase |
| Dose | 50 mg per flat dose |
| Route | p.o. |
| Schedule of Administration | Twice daily days 1–7 of 21‐day cycle |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.